Myriad Genetics Inc (MYGN)
Activity ratios
Short-term
Turnover ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | 9.17 | 9.70 | 9.51 | 9.82 | 10.74 | 9.10 | 9.84 | 9.78 | 10.05 | 9.89 | 12.42 | 12.52 | 12.92 | 10.69 | 11.03 | 7.25 | 6.57 | 6.79 | 6.40 | 6.49 |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Working capital turnover | 6.26 | 5.93 | 5.62 | 5.37 | 4.78 | 13.09 | 9.55 | 5.87 | 4.94 | 2.96 | 2.72 | 2.61 | 2.46 | 2.31 | 2.47 | 3.14 | 2.29 | 2.29 | 3.46 | 3.14 |
The inventory turnover ratio for Myriad Genetics Inc has shown fluctuations over the past few years. It ranged from a low of 6.40 in June 2020 to a high of 12.92 in December 2021, indicating varying efficiencies in managing and selling inventory. However, it has stabilized around 9.50-10.00 from September 2023 to December 2024.
The receivables turnover ratio data is not available, which prevents an assessment of the efficiency in collecting outstanding receivables from customers. The lack of this data limits our ability to evaluate the company's effectiveness in managing its accounts receivable.
Similarly, the payables turnover ratio data is also unavailable, preventing an analysis of how efficiently Myriad Genetics is managing its accounts payable and how quickly it pays off its suppliers.
The working capital turnover ratio demonstrates how effectively the company is utilizing its working capital to generate sales. Myriad Genetics saw a significant increase in this ratio from March 2023 to September 2023, indicating a substantial improvement in working capital efficiency during that period. However, the ratio has since stabilized around 5.00-6.00 from March 2024 to December 2024.
In conclusion, while the inventory turnover ratio has shown variability, the lack of data for receivables and payables turnover ratios has limited our comprehensive assessment of Myriad Genetics Inc's activity ratios. However, the working capital turnover ratio suggests fluctuations in working capital efficiency, with some periods of improvement followed by stabilization in recent years.
Average number of days
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 39.80 | 37.63 | 38.38 | 37.16 | 34.00 | 40.09 | 37.11 | 37.32 | 36.32 | 36.90 | 29.38 | 29.16 | 28.26 | 34.13 | 33.08 | 50.36 | 55.54 | 53.76 | 57.07 | 56.21 |
| Days of sales outstanding (DSO) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Myriad Genetics Inc's activity ratios can provide valuable insights into how efficiently the company manages its inventory and accounts receivable. The "Days of Inventory on Hand (DOH)" ratio measures how many days it takes for the company to sell its inventory. Over the period from March 31, 2020, to December 31, 2024, Myriad Genetics Inc's DOH fluctuated, ranging from a low of 28.26 days to a high of 57.07 days. A decreasing trend in DOH indicates that the company is managing its inventory more efficiently.
The "Days of Sales Outstanding (DSO)" ratio evaluates how long it takes for the company to collect its accounts receivable. Unfortunately, data for DSO was not provided, which limits our ability to assess the company's effectiveness in collecting payments from customers.
Lastly, the "Number of Days of Payables" ratio was also not available in the data provided. This ratio would have indicated how long it takes the company to pay its suppliers, giving insight into its payment practices and cash flow management.
In conclusion, based on the available data for Myriad Genetics Inc, the analysis of activity ratios suggests that the company has shown improvements in managing its inventory efficiently, but further information on accounts receivable and payables is needed to provide a more comprehensive assessment of its overall activity and liquidity management.
Long-term
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | — | — | — | — | — | — | 3.20 | 3.42 | 3.62 | 3.71 | 4.95 | 5.85 | 5.51 | 5.39 | 5.10 | 12.55 | 5.55 | 16.28 | 6.20 | 20.51 |
| Total asset turnover | 0.82 | 0.76 | 0.74 | 0.70 | 0.66 | 0.64 | 0.59 | 0.59 | 0.57 | 0.55 | 0.56 | 0.54 | 0.52 | 0.51 | 0.49 | 0.42 | 0.39 | 0.41 | 0.45 | 0.53 |
The Fixed Asset Turnover ratio for Myriad Genetics Inc has shown fluctuations over the period analyzed. It decreased from 20.51 in March 2020 to 3.20 in June 2023, indicating a decline in the efficiency of generating sales from fixed assets. However, it's important to note that the ratio stabilized at around 3.20 from June 2023 onwards.
In contrast, the Total Asset Turnover ratio displays a more consistent trend, steadily increasing from 0.53 in March 2020 to 0.82 in December 2024. This suggests that Myriad Genetics has been able to generate more sales relative to its total assets over the period.
The declining Fixed Asset Turnover ratio could signal potential inefficiencies in utilizing fixed assets, while the increasing Total Asset Turnover ratio indicates improving overall efficiency in utilizing all assets to generate sales. Further analysis of the company's fixed asset management practices and investment decisions could provide more insights into these trends.